In the majority of cells, the integrity of the plasmalemma is recurrently compromised by antagonist. Thus blebbing, which is elicited by the ATP-mediated, paracrine activation of the P2X7R, is part of a cellular non-immune defense mechanism. It pre-empts 2 plasmalemmal damage and promotes cellular survival. This mechanism is of considerable importance for cells of the immune system which carry the P2X7R and which are specifically exposed to toxin attacks.
INTRODUCTION
Serum complement or bacterial pore-forming toxins perforate the plasma membrane of a host cell and cause influx of extracellular -and efflux of cytoplasmic components, which might lead to cell death [1] [2] [3] [4] . It is thus not surprising that eukaryotic cells have developed membrane repair mechanisms and adapted them to suit the nature and severity of plasmalemmal injury [5] [6] [7] [8] -dependently to negatively-charged phospholipids [9] and have been ascribed a role in plasmalemmal repair [10] [11] [12] [13] .
Blebbing -a temporary detachment of the lipid bilayer from the submembranous cytoskeleton -is considered to be an early sign of intracellular Ca 2+ elevation, which indicates imminent or incipient membrane injury [14] . We have recently proposed blebbing to be a damage-control mechanism, which is triggered after the failure of plasmalemmal resealing [15] . The ability to bleb provides a clear benefit of survival for a cell confronted with attacks on its plasmalemma by pore-forming toxins [15] .
Since P2X7R activation is associated with an increase in membrane blebbing [16] , we have investigated the role of this receptor as a molecular regulator of plasma membrane protection after plasmalemmal perforation caused by the bacterial toxin SLO. The ionotropic P2X7R has two transmembrane domains; intracellular NH 2 -and COOH-termini and forms a homotrimer [17] . It is ubiquitously expressed, with high levels in immune cells and exists as a multiprotein complex, including the non-muscle myosin heavy chains and other cytoskeletal elements [18, 19] . The activation of the P2X7R by extracellular ATP opens a cationic channel which gradually dilates to a larger pore [20] [21] [22] . It is itself subject to regulation by numerous polymorphic variants and isoforms which increase or decrease its efficiency [23] . In macrophages primed by lipopolysaccharide, channel opening is additionally associated with the secretion of pro-inflammatory cytokines IL-1β [24, 25] and IL-18 [26, 27] . P2X7R activation is followed by downstream effects such as blebbing [28, 29] , microvesicle shedding [30, 31] , cell fusion [32] , proliferation [33] and eventually cell death [34] . Furthermore, in the absence of ATP, P2X7R plays a role in recognition and phagocytosis of foreign particles [35, 36] .
We demonstrate that the expression of the P2X7R confers resistance to the attack by bacterial pore-forming toxins. This protective effect can be increased by activation of the P2X7R with ATP and is abolished by pretreatment with blebbistatin or A-438079, a selective P2X7R antagonist. We further suggest that the paracrine activation of this receptor by ATP, released by damaged neighbouring cells, initiates blebbing and thus induces resistance to toxin-induced cell lysis. Blebbing is a characteristic feature of injured cells. It is thus conceivable that cells -in particular within inflammatory foci -use this ATPtriggered, P2X7R-mediated warning system to alert their neighbours to an approaching wave of bacterial toxins.
MATERIALS AND METHODS

Cell culture
HEK cells were maintained in DMEM (Dulbecco's modified Eagle's medium), containing 2 mM glutamax, 100 U/ml penicillin, 100 μg/ml streptomycin and 10% fetal calf serum (FCS) and were transfected as described [11, 37] . HEK cells stably transfected with the rat P2X7R (HEKrtP2X7) or the human P2X7R (HEKhuP2X7) [38] were cultured in DMEM/F12 medium supplemented with 2 mM glutamax, G418 (300 µg/ml), 2 mM MgCl2 and 10%
FCS. HMC-1 were cultured in IMDM with 10% FCS, 100 U/ml penicillin and 100 μg/ml streptomycin as described [39] . All cells were grown in 5% CO 2 at 37°C in a humidified incubator. For the viability experiments, the cells were challenged with 750 U/ml SLO from [40] ). To inhibit P2X7R-specific ATP stimulation, the cells were incubated with 1 µM or 10 µM A-438079 (Sigma-Aldrich, Buchs, Switzerland) for 15 min at RT.
Expression of annexins as fusions with fluorescent proteins
The coding sequences of annexin A1 and A2 were cloned into the Living Colors 
Imaging
Glass coverslips with annexin-expressing HEK cells were mounted in a perfusion chamber at RT in Tyrode's buffer containing 2.5 mM CaCl 2 . To induce blebbing, the ATP analogue META (Carl Zeiss AG, Feldbach, Switzerland) using a 63x oil immersion lens. The images were analyzed using the 'Zeiss LSM Image examiner' software package (Carl Zeiss AG).
To determine the percentage of lysis, the number of cells with annexin A1 translocation was divided by the total cell number [15] . Transient plasmalemmal translocations of fluorescently-labeled annexin A2 were used to monitor elevations of intracellular Ca 2+ in the low micromolar range [11, 42] .
Numerical data are expressed as mean values together with the standard error. The statistical analyses were performed using GraphPad Prism 5.04 and Microsoft Excel 2010.
The level of significance was set at p<0.05. Significant differences are marked with asterisks.
Western blotting
HEK, HEKrtP2X7 and HEKhuP2X7 cells were resuspended in SDS sample buffer (200 mM Tris-HCl, 40 mM EGTA, pH 7, 3.1% SDS, 7.7% β-mercaptoethanol, 13.4% glycerol and 60 µg/ml of bromophenol blue) and boiled for 1 min. Samples were run on 8% SDSpolyacrylamide minigels together with a molecular weight marker (Page Ruler Prestained, Thermo Scientific, Erembodegem, Belgium). Equal amounts of protein were loaded for the different protein extracts as estimated by a test gel. Blotting was carried out overnight onto a PVDF membrane (Millipore AG, Zug, Switzerland). Unspecific binding sites were blocked with 4% non-fat dry milk in low salt buffer (0.9% NaCl, 10 mM Tris-Base, 0.1% Tween 20) for 1 h at RT. Primary antibodies (polyclonal rabbit-anti-P2X7, Alomone Labs, Jerusalem, Israel) were diluted in low salt buffer supplemented with 2% non-fat milk powder and incubated for 1 h at RT. The blot was washed 3 times with low salt buffer for 10 min.
Secondary antibodies (HRP-donkey-anti-rabbit IgG, GE Healthcare, Glattbrugg, Switzerland) were diluted in low salt buffer supplemented with 2% non-fat milk powder and incubated for 45 min at RT. Finally, the blot was washed again 3 times with low salt buffer for 10 min. Chemiluminescence reaction was performed using Western Bright ECL from Advansta (Menlo Park, CA, USA) and the signal was detected by a Fusion FX imaging system (Vilber Lourmat, Marne-la-Vallée, France).
RESULTS
In order to investigate P2X7R function in plasmalemmal repair, we initially applied a well characterized model system (HEK cells), in which blebbing has previously been associated with increased survival [15] . We confirmed that the transcription ( Figure 1A) and protein expression ( Figure 1B ) of P2X7R occurred in HEK cells stably transfected with the P2X7R gene, but not in control cells. Immunostaining with antibodies against the P2X7R demonstrated that it was localized to the plasmalemma, as previously described, whereas untransfected HEK cells were devoid of signal ( Figure 1C ).
The activation of a functional P2X7R leads to an increase in [Ca 2+ ], followed by blebbing [43, 44] . Therefore, the functionality of the P2X7R in stably transfected HEK cells was ] ielevation above 20 µM) [15] . Figure 3A shows that the expression of the P2X7R alone confers resistance against SLO toxicity. HEKrtP2X7 cells showed a significantly lower amount of SLO-induced lysis (59.5%±6.4%, t-test: P<0.001; 147 cells on 11 slides) compared to the wild-type cells (100%±4.8%, 187 cells on 13 slides). As expected, the P2X7R stimulation with ATP prior to toxin incubation led to an additional reduction of lysis ( Figure 3B ; 24.4%±7.7%, t-test: P<0.01, 277 cells on 14 slides). Representative confocal micrographs depict the extent of annexin A1 translocation during the experimental conditions described above ( Figure 3C ).
To elucidate the role of Ca 2+ in the protective effect of the P2X7R, we performed alamarBlue® cell viability assays [40] . In the presence of extracellular Ca
2+
, an increased viability was observed in HEKrtP2X7 cells compared to non-transfected HEK cells ( Figure   3D ). Correspondingly, we could detect significantly more blebbing in HEKrtP2X7 cells compared to HEK cells (44.5±9.9% versus 27.1±4.7%) after SLO-treatment ( Figure 3E ).
Such protective effect was lacking in the absence of extracellular Ca 2+ and the viability after treatment with SLO at Ca 2+ -free conditions was drastically reduced in both cell types.
Our data demonstrate that the P2X7R has a protective effect, which is dependent on the in P2X7 transfected cells resulting in stronger blebbing.
We next investigated whether membrane blebbing was responsible for the protection against lysis. Blebbing -and its concomitant positive effect on cellular survival mediated by the P2X7R -was inhibited by pretreatment with blebbistatin ( Figure 4A ; 513 cells on 27 slides; Figure 4B ), an agent that is known to interact with non-muscle myosin II and to inhibit blebbing [48] .
To determine if ATP is a P2X7R-specific mediator of this process, we treated HEKrtP2X7 cells with A-438079, a selective P2X7R antagonist, which reversibly blocks rat and human P2X7R and inhibits BzATP induced IL-1β release as well as pore formation [49] .
Pretreatment with A-438079 before the incubation with ATP (30 µM) and SLO treatment, led to a complete abolishment of the ATP-mediated protective effect ( Figure 5A ; 33 measurements in 3 independent AlamarBlue® assays).
The physiological significance of our findings were emphasized in experiments with HMC-1, which express the P2X7R endogenously [50] . Viability was significantly increased after pretreatment of the mast cells with ATP prior to toxin exposure ( Figure 5B ; from 17.7±1.3%
to 32.1±1.6%; 34 measurements in 3 independent assays) and abolished by pretreatment with A-438079.
DISCUSSION
The P2X7R has been proposed to function as a regulator of inflammation [51] . In systemic illnesses such as rheumatoid arthritis, the activation of the P2X7R is associated with an increase in the secretion of proinflammatory cytokines and an exacerbation of the disease [52] . Its prolonged activation leads to apoptotic cell death [53] and its absence has been linked to a diminished output of inflammatory mediators such as IL-1 [54] . ATP is considered a physiological ligand of the P2X7R, which in vivo is released from viable or dying cells or from degranulating platelets [55] [56] [57] . In view of its effect on neighbouring cells, ATP has been identified as an endogenous danger signal with potentially detrimental effects when it is released into the extracellular space after tissue damage [58] .
Numerous studies have addressed the frequently deleterious consequences for an organism, which is flooded with proinflammatory cytokines following P2X7R activation [52, 58] . Conversely, the absence or loss-of-function of the P2X7R has been shown to diminish cellular host defenses against pathogens such as Chlamydia [59] or Toxoplasma gondii [60] .
Our study addresses the role of P2X7R activation in the survival of cells subjected to an attack by bacterial toxins. Exposed to an often unfavorable environment and threatened by the exposure to bacterial toxins, cellular survival is critically dependent on an early warning system in combination with efficient plasmalemmal repair.
Plasmalemmal repair can be achieved by different Ca 2+ -dependent mechanisms:
eukaryotic cells are capable of patching injured regions with internal membranes transported to the surface of the cell by exocytosis [5] or of resealing the plasma membrane by endocytosis of the damaged sites [6, 61] . Microparticle shedding has been shown to play a role in the quarantining and elimination of injured plasmalemmal regions [8, 62] .
Previous studies have associated enhanced P2X7R activity with plasmalemmal blebbing [21, 63] and microvesicle shedding [30] as well as with the death of injured cells [14, 64] .
In addition, blebs play also a role in cellular migration [46, 65, 66] . We have recently proposed that blebs confer resistance to toxin-induced plasmalemmal injury by acting as a trap for the damaged membrane region, which is sealed off from the cell body [15] .
Proteins of the annexin family are able to sense elevated [Ca 2+ ] i [42] . In the presence of Ca 2+
, annexin A1 aggregates and fuses biological membranes [9, [67] [68] [69] . Exposed to a strong flux of Ca 2+ in the vicinity of a toxin pore, annexin A1 binds to the plasmalemma within the bleb and cross-links the adjacent membranes of its slender neck, thus forming a plug that creates two separate compartments. This process enables the cell to repair its plasmalemma within the bleb without endangering the cell body. After membrane integrity has been restored and Ca 2+ homeostasis has been re-established, annexin A1
translocates back to the cytoplasm thereby dissolving the plug [13] .
Stimulation of the P2X7R (by ATP or its analogue BzATP) leads to the opening of a cation channel [21] and Ca 2+ influx, which initiates blebbing [28] and microparticle release [30] .
Our data show that the expression of the P2X7R alone improves the survival of cells during attacks by the pore-forming bacterial toxin SLO. This protective effect is even more pronounced if the receptor is stimulated with its physiological ligand ATP prior to toxin exposure. In addition, this effect can be inhibited by pretreatment with blebbistatin or a specific P2X7R antagonist.
CONCLUSIONS
Plasmalemmal blebbing constitutes an intricate cellular defense system: on the one hand, blebbing allows the cell to isolate the damaged plasmalemmal segment and protects the cell body from further injury by restricting the elevated intracellular [Ca 2+ ] to the blebs [15] , on the other hand, the release of ATP from the injured cell acts as a paracrine stimulus and induces blebbing by activating the P2X7 receptors of cells in the vicinity (Figure 6 ).
Our study underlines the important role of P2X7R-induced blebbing as part of a nonimmune defense mechanism against bacterial pore-forming toxins. Since the P2X7R is particularly prevalent in cells of the immune system [70] , this mechanism warns and shields those cells, which are in the first line of toxin attacks.
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